Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
We provide 1 form of Zanubrutinib
Zanubrutinib
1691249-45-2
|
471.551
|
2.847
Zanubrutinib is an inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, zanubrutinib inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor signaling pathway.
BGB-3111 | Brukinsa | zanubrutinib
Zanubrutinib is an inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, zanubrutinib inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor signaling pathway.
BGB-3111 | Brukinsa | zanubrutinib
$240/5 mg
(EBC)
1
We provide 0 compound for Zanubrutinib
